News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,407 Results
Type
Article (43137)
Company Profile (305)
Press Release (661965)
Section
Business (211564)
Career Advice (2152)
Deals (37011)
Drug Delivery (95)
Drug Development (83709)
Employer Resources (172)
FDA (16513)
Job Trends (15502)
News (358202)
Policy (34297)
Tag
Academia (2606)
Africa (801)
Alliances (51589)
Alzheimer's disease (1166)
Approvals (16437)
Arizona (182)
Artificial intelligence (79)
Asia (40596)
Australia (6416)
Bankruptcy (366)
Best Places to Work (11459)
Biosimilars (70)
Biotechnology (195)
C2C Services and Suppliers (80017)
California (1781)
Canada (906)
Cancer (415)
Career advice (1789)
Cell therapy (118)
China (137)
Clinical research (65481)
Collaboration (133)
Colorado (71)
Compensation (72)
Connecticut (71)
COVID-19 (2576)
Cystic fibrosis (74)
Data (226)
Diabetes (85)
Diagnostics (6073)
Drug pricing (76)
Earnings (85737)
Employer resources (148)
Europe (86584)
Events (111681)
Executive appointments (137)
FDA (16714)
Florida (255)
Funding (133)
Gene therapy (98)
GLP-1 (567)
Government (4469)
Healthcare (18922)
Hotbed/Location (492324)
Illinois (253)
Indiana (149)
Infectious disease (2604)
Inflammatory bowel disease (93)
Interviews (335)
IPO (16616)
Job creations (4150)
Job search strategy (1545)
Kansas (94)
Layoffs (427)
Legal (8431)
Lung cancer (98)
Manufacturing (89)
Maryland (377)
Massachusetts (1480)
Medical device (13163)
Medtech (13168)
Mergers & acquisitions (20220)
Metabolic disorders (275)
Michigan (123)
Minnesota (211)
Neuroscience (1310)
New Jersey (548)
New York (562)
NextGen Class of 2024 (6693)
Non-profit (4528)
North Carolina (614)
Northern California (790)
Obesity (167)
Ohio (104)
Opinion (212)
Patents (72)
Pennsylvania (563)
People (58258)
Pharmaceutical (88)
Phase I (20300)
Phase II (28770)
Phase III (21613)
Pipeline (105)
Postmarket research (2666)
Preclinical (8584)
Press Release (68)
Rare diseases (133)
Real estate (6337)
Recruiting (65)
Regulatory (22320)
Research institute (2376)
Resumes & cover letters (367)
South America (1172)
Southern California (712)
Startups (3775)
Texas (226)
United States (8290)
Vaccines (488)
Washington State (247)
Weight loss (155)
Date
Today (132)
Last 7 days (623)
Last 30 days (2285)
Last 365 days (38165)
2024 (26230)
2023 (40928)
2022 (52114)
2021 (56677)
2020 (55113)
2019 (47824)
2018 (36141)
2017 (33572)
2016 (33169)
2015 (39008)
2014 (32960)
2013 (28078)
2012 (30165)
2011 (30871)
2010 (28889)
705,407 Results for "antares pharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Astellas Pharma Opens Cambridge Life Sciences Center Featuring Incubator Space
Astellas Pharma’s new life sciences center houses its first U.S.-based SakuLab, an incubator space for external partners, as well as its engineered small molecules unit.
September 6, 2024
·
1 min read
·
Angela Gabriel
Business
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.First Commercial Agreement for DispersinB®
Kane Biotech Inc. announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) for the DispersinB ® technology.
June 25, 2024
·
3 min read
Deals
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
Agile Therapeutics, Inc. today announced that it has entered into a definitive merger agreement (“Merger Agreement”) with Insud Pharma, S.L.
June 26, 2024
·
10 min read
Pharm Country
Mitsubishi Tanabe Pharma America, Inc. (MTPA) Stands with the ALS Community
Mitsubishi Tanabe Pharma America, Inc. is aware of recent external challenges facing the amyotrophic lateral sclerosis treatment landscape.
May 23, 2024
·
6 min read
Business
Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights
Nuvectis Pharma, Inc. reported its financial results for the first quarter 2024 and provided an update on recent business progress.
May 7, 2024
·
8 min read
Opinion
Opinion: A Small Pharma Mindset Can Reshape Big Pharma and Improve Patient Care
An appreciation for practicality, independent thinking and patient care can help disrupt the bureaucracy of Big Pharma.
September 12, 2024
·
3 min read
·
Jill Marie Drury
Business
Zylö announces the creation and spinout of Atticus Pharma Inc.
Zylö recently effected a spinout of Atticus Pharma Inc., whose mission is to unlock the value of the Z-pod ® topical delivery platform in the pharmaceutical vertical.
April 17, 2024
·
3 min read
Pharm Country
Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference - May 16, 2024
Nuvectis Pharma, Inc. today announced that Ron Bentsur, Chairman and Chief Executive Officer, will present at the H.C. Wainwright 2nd BioConnect Investor Conference at the NASDAQ world headquarters in New York City.
May 16, 2024
·
1 min read
Approvals
ARS Pharma Gets FDA Green Light for First Nasal Spray for Severe Allergic Reactions
ARS Pharma’s neffy on Friday became the first FDA-approved nasal spray to address severe allergic reactions, including those that might lead to life-threatening anaphylaxis.
August 12, 2024
·
2 min read
·
Tristan Manalac
Business
FSD Pharma provides Corporate Update
FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions is pleased to provide the following corporate update.
June 28, 2024
·
10 min read
1 of 70,541
Next
